{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:56:48Z","timestamp":1790823408861,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":548,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MSLH-389"],"award-info":[{"award-number":["2023-MSLH-389"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200227"],"award-info":[{"award-number":["82200227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.exphem.2024.104709","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T20:11:41Z","timestamp":1736021501000},"page":"104709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The diagnostic and therapeutic potential of multiple myeloma\u2013associated circular RNAs"],"prefix":"10.1016","volume":"144","author":[{"given":"Yue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaokun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104709_bib0001","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.exphem.2024.104709_bib0002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2024.104709_bib0003","first-page":"470","article-title":"The diagnosis and treatment of multiple myeloma","volume":"113","author":"Gerecke","year":"2016","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"10.1016\/j.exphem.2024.104709_bib0004","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104709_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2024.104709_bib0006","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1470-2045(03)01195-1","article-title":"New insights into the pathophysiology of multiple myeloma","volume":"4","author":"Seidl","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2024.104709_bib0007","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2024.104709_bib0008","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1101\/SQB.1974.038.01.096","article-title":"An electron microscope study of Sindbis virus RNA","volume":"38","author":"Hsu","year":"1974","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.exphem.2024.104709_bib0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.exphem.2024.104709_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104709_bib0011","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2024.104709_bib0012","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.canlet.2017.03.027","article-title":"Circular RNAs and cancer","volume":"396","author":"He","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.exphem.2024.104709_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145182","article-title":"The roles of circRNAs in cancers: perspectives from molecular functions","volume":"767","author":"Cao","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.exphem.2024.104709_bib0014","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","journal-title":"RNA Biol"},{"key":"10.1016\/j.exphem.2024.104709_bib0015","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1261\/rna.047126.114","article-title":"Circular RNAs: diversity of form and function","volume":"20","author":"Lasda","year":"2014","journal-title":"RNA"},{"key":"10.1016\/j.exphem.2024.104709_bib0016","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biochem.72.121801.161720","article-title":"Mechanisms of alternative pre-messenger RNA splicing","volume":"72","author":"Black","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2024.104709_bib0017","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104709_bib0018","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1002\/wrna.1583","article-title":"tRNA introns: presence, processing, and purpose","volume":"11","author":"Schmidt","year":"2020","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.exphem.2024.104709_bib0019","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","article-title":"The biogenesis of nascent circular RNAs","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2024.104709_bib0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","article-title":"Complementary sequence-mediated exon circularization","volume":"159","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104709_bib0021","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","article-title":"circRNA biogenesis competes with pre-mRNA splicing","volume":"56","author":"Ashwal-Fluss","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104709_bib0022","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1101\/gad.251926.114","article-title":"Short intronic repeat sequences facilitate circular RNA production","volume":"28","author":"Liang","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2024.104709_bib0023","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature08909","article-title":"Expansion of the eukaryotic proteome by alternative splicing","volume":"463","author":"Nilsen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104709_bib0024","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/nar\/gkv1367","article-title":"Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor","volume":"44","author":"Enuka","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0025","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/nar\/gkw027","article-title":"Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2","volume":"44","author":"Du","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0026","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104709_bib0027","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","article-title":"Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis","volume":"37","author":"Hanniford","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2024.104709_bib0028","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2147\/CMAR.S280315","article-title":"Circular RNA circCDYL regulates proliferation and apoptosis in non-small cell lung cancer cells by sponging miR-185-5p and upregulating TNRC6A","volume":"13","author":"Bian","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0029","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4149\/gpb_2019037","article-title":"circCDYL\/microRNA-105-5p participates in modulating growth and migration of colon cancer cells","volume":"38","author":"Cui","year":"2019","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.exphem.2024.104709_bib0030","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/1535370220918191","article-title":"Circular RNA circ-CDYL sponges miR-1180 to elevate yes-associated protein in multiple myeloma","volume":"245","author":"Chen","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.exphem.2024.104709_bib0031","doi-asserted-by":"crossref","first-page":"10215","DOI":"10.2147\/CMAR.S232075","article-title":"CircCDYL serves as a new biomarker in mantle cell lymphoma and promotes cell proliferation","volume":"11","author":"Mei","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0032","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.30795","article-title":"A noncoding regulatory RNAs network driven by circ-CDYL acts specifically in the early stages hepatocellular carcinoma","volume":"71","author":"Wei","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.exphem.2024.104709_bib0033","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1080\/15384101.2020.1839701","article-title":"Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p\/JAG1 axis","volume":"19","author":"Wang","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2024.104709_bib0034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11845-023-03410-w","article-title":"The quantification of circular RNA 0007841 during induction therapy helps estimate the response and survival benefits to bortezomib-based regimen in multiple myeloma","volume":"193","author":"Guo","year":"2024","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.exphem.2024.104709_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-019-1071-9","article-title":"CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p\/MAPK4 pathway","volume":"38","author":"Feng","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0036","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11845-021-02586-3","article-title":"Circular RNA_0000190 and its target microRNA-767-5p are dysregulated, and they are related to risk stratification as well as prognosis in multiple myeloma patients","volume":"191","author":"Xiang","year":"2022","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.exphem.2024.104709_bib0037","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nsmb.2959","article-title":"Exon-intron circular RNAs regulate transcription in the nucleus","volume":"22","author":"Li","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.exphem.2024.104709_bib0039","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1038\/nplants.2017.53","article-title":"A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation","volume":"3","author":"Conn","year":"2017","journal-title":"Nat Plants"},{"key":"10.1016\/j.exphem.2024.104709_bib0040","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.2019000802","article-title":"circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression","volume":"134","author":"Sun","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104709_bib0041","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13577-020-00441-8","article-title":"circRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma","volume":"34","author":"Yu","year":"2021","journal-title":"Hum Cell"},{"key":"10.1016\/j.exphem.2024.104709_bib0042","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.18632\/aging.102122","article-title":"A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt\/\u03b2-catenin signaling via interacting with TET1 and miR-888","volume":"11","author":"Hu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.exphem.2024.104709_bib0043","first-page":"1402","article-title":"Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses","volume":"38","author":"Du","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.exphem.2024.104709_bib0044","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/cdd.2017.86","article-title":"A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation","volume":"24","author":"Yang","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2024.104709_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.10.035","article-title":"Unorthodox mechanisms to initiate translation open novel paths for gene expression","volume":"432","author":"Hern\u00e1ndez","year":"2020","journal-title":"J Mol Biol"},{"key":"10.1016\/j.exphem.2024.104709_bib0046","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2024.104709_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107641","article-title":"Modulation of circRNA metabolism by m6A modification","volume":"31","author":"Di Timoteo","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2024.104709_bib0048","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12943-021-01380-0","article-title":"CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma","volume":"20","author":"Gu","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.exphem.2024.104709_bib0049","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41392-021-00746-6","article-title":"BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.exphem.2024.104709_bib0050","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41374-018-0108-6","article-title":"Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies","volume":"98","author":"Dahl","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.exphem.2024.104709_bib0051","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4274\/tjh.galenos.2020.2020.0243","article-title":"Circulating exosomal CircMYC is associated with recurrence and bortezomib resistance in patients with multiple myeloma","volume":"37","author":"Luo","year":"2020","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.exphem.2024.104709_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109872","article-title":"Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy","volume":"78","author":"Zhang","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.exphem.2024.104709_bib0053","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12935-021-02011-w","article-title":"Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage","volume":"21","author":"Sun","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.exphem.2024.104709_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113229","article-title":"Exosomal circ-CACNG2 promotes cardiomyocyte apoptosis in multiple myeloma via modulating miR-197-3p\/caspase3 axis","volume":"417","author":"Yu","year":"2022","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2024.104709_bib89","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/21655979.2021.2012553","article-title":"A novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis","volume":"13","author":"Yu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.exphem.2024.104709_bib0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12935-020-01475-6","article-title":"Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p\/BRD4 signaling cascade","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.exphem.2024.104709_bib0056","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820928371","article-title":"Hsa_Circ_0007841 enhances multiple myeloma chemotherapy resistance through upregulating ABCG2","volume":"19","author":"Song","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.exphem.2024.104709_bib0057","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3389\/fonc.2019.01261","article-title":"hsa_circ_0007841: a novel potential biomarker and drug resistance for multiple myeloma","volume":"9","author":"Gao","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2024.104709_bib0058","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jb\/mvaa106","article-title":"Upregulation of circ_0000142 promotes multiple myeloma progression by adsorbing miR-610 and upregulating AKT3 expression","volume":"169","author":"Liu","year":"2021","journal-title":"J Biochem"},{"key":"10.1016\/j.exphem.2024.104709_bib0059","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.2147\/CMAR.S241089","article-title":"hsa_circRNA_101237: a novel diagnostic and prognostic biomarker and potential therapeutic target for multiple myeloma","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0060","doi-asserted-by":"crossref","first-page":"e3329","DOI":"10.1002\/jgm.3329","article-title":"Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via miR-874-3p\/HDAC1 axis","volume":"23","author":"Tian","year":"2021","journal-title":"J Gene Med"},{"key":"10.1016\/j.exphem.2024.104709_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100381","article-title":"CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p","volume":"30","author":"Fang","year":"2021","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.exphem.2024.104709_bib0062","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/16078454.2021.1974199","article-title":"CircRNA circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma","volume":"26","author":"Liu","year":"2021","journal-title":"Hematology"},{"key":"10.1016\/j.exphem.2024.104709_bib0063","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/CAD.0000000000001166","article-title":"Circular RNA circ-CCT3 promotes bortezomib resistance in multiple myeloma via modulating miR-223-3p\/BRD4 axis","volume":"33","author":"Liu","year":"2022","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.exphem.2024.104709_bib0064","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12885-020-6515-2","article-title":"Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2024.104709_bib0065","article-title":"Circular RNA protein tyrosine kinase 2 promotes cell proliferation, migration and suppresses apoptosis via activating MicroRNA-638 mediated MEK\/ERK, WNT\/\u03b2-catenin signaling pathways in multiple myeloma","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2024.104709_bib0066","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s10528-022-10228-1","article-title":"CircATIC contributes to multiple myeloma progression via miR-324-5p-dependent regulation of HGF","volume":"60","author":"Wu","year":"2022","journal-title":"Biochem Genet"},{"key":"10.1016\/j.exphem.2024.104709_bib0067","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13018-023-03832-3","article-title":"Circ_0005615 restrains the progression of multiple myeloma through modulating miR-331-3p and IGF1R regulatory cascade","volume":"18","author":"Zhang","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0068","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/CAD.0000000000001378","article-title":"Circ_0005615 contributes to the progression and bortezomib resistance of multiple myeloma by sponging miR-185-5p and upregulating IRF4","volume":"33","author":"Fu","year":"2022","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.exphem.2024.104709_bib0069","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s13018-021-02867-8","article-title":"Down-regulation of circ_0058058 suppresses proliferation, angiogenesis and metastasis in multiple myeloma through miR-338-3p\/ATG14 pathway","volume":"16","author":"Xue","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jphs.2022.01.013","article-title":"Circular RNA circPSAP functions as an efficient miR-331-3p sponge to regulate proliferation, apoptosis and bortezomib sensitivity of human multiple myeloma cells by upregulating HDAC4","volume":"149","author":"Ma","year":"2022","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.exphem.2024.104709_bib0071","first-page":"525","article-title":"CircKCNQ5 controls proliferation, migration, invasion, apoptosis, and glycolysis of multiple myeloma cells by modulating miR-335-5p\/BRD4 axis","volume":"38","author":"Li","year":"2023","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.exphem.2024.104709_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106774","article-title":"Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p\/CDK6 axis","volume":"113","author":"Luo","year":"2022","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0073","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s12033-022-00618-6","article-title":"Hsa_Circ_0134426 attenuates the malignant biological behaviors of multiple myeloma by suppressing miR-146b-3p to upregulate NDNF","volume":"65","author":"Li","year":"2023","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.exphem.2024.104709_bib0074","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/dna.2023.0288","article-title":"Circular RNA circXPO1 promotes multiple myeloma progression by regulating miR-495-3p\/DNA damage-induced transcription 4 axis","volume":"43","author":"Li","year":"2024","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.exphem.2024.104709_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107451","article-title":"Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5","volume":"141","author":"Zhu","year":"2024","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118506","article-title":"CircRNA ITCH increases bortezomib sensitivity through regulating the miR-615-3p\/PRKCD axis in multiple myeloma","volume":"262","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.exphem.2024.104709_bib0078","doi-asserted-by":"crossref","first-page":"11321","DOI":"10.2147\/CMAR.S259393","article-title":"Effect of the up-regulation of circular RNA Hsa_circ_0069767 derived from C-KIT on the biological behavior of multiple myeloma cells","volume":"12","author":"Chen","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0079","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.arcmed.2023.05.002","article-title":"Hsa_circ_0111738 inhibits tumor progression and angiogenesis in multiple myeloma by sponging miR-1233-3p to regulate HIF-1 signaling pathway","volume":"54","author":"Wang","year":"2023","journal-title":"Arch Med Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/kjm2.12504","article-title":"Icaritin-elevated circ_0000190 suppresses the malignant progression of multiple myeloma by targeting miR-301a","volume":"38","author":"Zhu","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.exphem.2024.104709_bib0081","doi-asserted-by":"crossref","first-page":"335","DOI":"10.21037\/tcr.2019.12.71","article-title":"Potential of circular RNA itchy E3 ubiquitin protein ligase as a biomarker and treatment target for multiple myeloma","volume":"9","author":"Zhou","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.exphem.2024.104709_bib0082","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1186\/s12885-019-6088-0","article-title":"Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2024.104709_bib0083","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1002\/hem3.34","article-title":"Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R-ISS II patients","volume":"8","author":"Papatsirou","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.exphem.2024.104709_bib0084","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/or.2022.8410","article-title":"Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomibbased treatment response and survival via the microRNA608mediated Wnt\/\u03b2catenin pathway","volume":"48","author":"Li","year":"2022","journal-title":"Oncol Rep"},{"key":"10.1016\/j.exphem.2024.104709_bib0087","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.exphem.2024.104709_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1383232","article-title":"N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair","volume":"12","author":"Jiang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.exphem.2024.104709_bib0086","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/cancers13020216","article-title":"Signaling pathway mediating myeloma cell growth and survival","volume":"13","author":"Hideshima","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.exphem.2024.104709_bib0088","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/cancers13030365","article-title":"Genome-wide circular RNA expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells","volume":"13","author":"Jakobsen","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:20:31Z","timestamp":1790821231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24005733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":87,"alternative-id":["S0301472X24005733"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104709","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic and therapeutic potential of multiple myeloma\u2013associated circular RNAs","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104709"}}